Top Markets
Coin of the day
Nuformix plc Nuformix plc

Nuformix plc

NFX
Classement en actions #41014
Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes... Nuformix plc, a pharmaceutical company based in the United Kingdom, specializes in developing therapies for fibrotic diseases and cancer, primarily through the innovative strategy of drug repurposing. Its current development portfolio includes NXP001, which has advanced beyond Phase 1 trials for application in oncology supportive care. Additionally, the company is progressing NXP004, a novel variant of Olaparib, currently in its intellectual property generation stage for oncological indications, and NXP002, which is undergoing pre-clinical evaluation for the treatment of idiopathic pulmonary fibrosis. Nuformix also holds an option agreement with Oxilio Ltd. concerning NXP001 for its oncology applications. Established in 2008, the company maintains its operational base in London.
Prix de l'action
$0.00185055
Capitalisation boursière
$48.29K
Changement (1 jour)
-3.55%
Changement (1 an)
30.31%
Pays
GB
Échange Nuformix plc (NFX)

Catégorie

Historique des dividendes pour Nuformix plc (NFX)
Nuformix plc (symbole boursier : NFX) a versé un total de 0 dividendes.
Le total des dividendes (ajusté en fonction des divisions d’actions) est de : 0.00
Rendement du dividende (TTM) : 0
Versements de dividendes pour Nuformix plc (NFX) de 2026 à 2026
Versements annuels de dividendes
Année Dividende (ajusté pour divisions d’actions) Changez
Pas assez de données pour les dates fournies.
Liste de tous les paiements de dividendes
Année Dividende Changez
Pas assez de données pour les dates fournies.
Dividendes versés par des entreprises similaires ou concurrentes
Entreprise Nombre de paiements de dividendes Pays
0.00%
US
0.00%
US
64.00%
AU
0.00%
NL
0.00%
CH